Laparoscopic Adjustable Gastric Banding Versus Laparoscopic Sleeve Gastrectomy

NCT ID: NCT00434655

Last Updated: 2009-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* The investigators aim to determine the clinical and metabolic outcomes of two available bariatric restrictive procedures: laparoscopic adjustable gastric banding (LAP-BAND) and laparoscopic sleeve gastrectomy for the treatment of morbid obesity (BMI \> 35 with comorbidities or BMI \> 40) in VETERANS.
* The investigators hypothesize that the short and long term outcomes between laparoscopic adjustable gastric banding (LAP-BAND) and sleeve gastrectomy are similar in VETERANS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a bariatric surgery Phase 3 prospective trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morbid Obesity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Morbid obesity Bariatric surgery Obesity surgery Gastric banding Sleeve gastrectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 LAP BAND

Group Type ACTIVE_COMPARATOR

Laparoscopic restrictive procedure

Intervention Type PROCEDURE

Morbidly Obese VETERANS will receive one of two laparoscopic bariatric restrictive procedures.

2 Sleeve gastrectomy

Group Type EXPERIMENTAL

Laparoscopic restrictive procedure

Intervention Type PROCEDURE

Morbidly Obese VETERANS will receive one of two laparoscopic bariatric restrictive procedures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic restrictive procedure

Morbidly Obese VETERANS will receive one of two laparoscopic bariatric restrictive procedures.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Morbidly obese VETERANS ONLY (BMI\>35 with comorbidities or BMI \> 40)
* Age \> 18 y/o

Exclusion Criteria

* Pregnancy
* Severe uncontrolled medical or psychiatric conditions
* Previous bariatric surgery
* Multiple previous abdominal surgeries
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

North Texas Veterans Healthcare System

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

North Texas VA

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esteban Varela, MD

Role: PRINCIPAL_INVESTIGATOR

VA North Texas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA North Texas

Dallas, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07-010

Identifier Type: -

Identifier Source: org_study_id